Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
Neuropsicofarmacología geriátrica: una guía sobre dosificación y monitoreo de sustancias psicotrópicas en la población geriátrica
1
x
$
0.00
Oral Muscle Relaxants for the Treatment of Chronic Pain Associated with Cerebral Palsy
1
x
$
30.00
A Comprehensive Review of Solriamfetol to Treat Excessive Daytime Sleepiness
1
x
$
30.00
Takefumi Suzuki - Treatment Target in Schizophrenia: A Critical Review and a Clinical Suggestion
1
x
$
30.00
Rating Scales and Safety Measurements in Bipolar Disorder and Schizophrenia – A Reference Guide
1
x
$
0.00
Gregor E. Berger, MD, FMH Psych (CH): Incipient Neurovulnerability and Neuroprotection in Early Psychosis
1
x
$
30.00
The Next Step Forward: A Move Toward Evidence, and Away From Fear of the Industry
1
x
$
0.00
Major (ICD-10) Depression Inventory
1
x
$
0.00
Efficacy of Rivastigmine Augmentation on Positive and Negative Symptoms, General Psychopathology, and Quality of Life in Patients with Chronic Schizophrenia: A Randomized Controlled Trial
1
x
$
30.00
James H. Kocsis, MD: Continuation Treatment of Chronic Depression: A Comparison of Nefazodone, Cognitive Behavioral Analysis System of Psychotherapy, and Their Combination
1
x
$
30.00
C. Lindsay DeVane, PharmD: Charleston Antidepressant Drug Interactions Surveillance Program (CADISP)
1
x
$
30.00
Jefferson B. Prince, MD: Citalopram for the Treatment of Adolescent Anxiety Disorders: A Pilot Study
1
x
$
30.00
Pharmacy Practice: Monitoring Chemotherapy in an Aging Population
1
x
$
0.00
Intercambio y inovación: la cosmología psiquiátrica
1
x
$
0.00
La fobia social en una muestra de pacientes Españoles con trastorno de pánico
1
x
$
0.00
View Cart
Checkout
Home
Store
“La fobia social en una muestra de pacientes Españoles con trastorno de pánico” has been added to your cart.
View cart
Sort by
Name
Sort by
Name
Sort by
Price
Sort by
Date
Sort by
Popularity
Show
20 Products
Show
20 Products
Show
40 Products
Show
60 Products
Letter From the Editors: Are We Prepared for the Genomics Era?
$
0.00
Add to cart
Details
Letter From the Editors: Are You Ready For Some Ethics, Some Success, Some Cytoprotectants, and Some New Board Members?
$
0.00
Add to cart
Details
Letter From the Editors: Lymphomas – The Diseases That Taught Us Monoclonal Antibodies Can Work
$
0.00
Add to cart
Details
Letter From the Editors: Right Tool, Right Time, Right Reason
$
0.00
Add to cart
Details
Letter to the Editor: AGGRAVATION OF SCHIZOPHRENIA BY CLOMIPRAMINE IN A PATIENT WITH COMORBID OBSESSIVE-COMPULSIVE DISORDER
$
0.00
Add to cart
Details
LETTER TO THE EDITOR: GLUCOSE TESTING IN PATIENTS RECEIVING ANTIPSYCHOTIC PHARMACOTHERAPY
$
0.00
Add to cart
Details
Lidocaine Ineffectiveness Suggests New Psychopharmacology Drug Target
$
30.00
Add to cart
Details
Lieuwe de Haan, MD, PhD: Reliability and Validity of the Yale-Brown Obsessive-Compulsive Scale in Schizophrenia Patients
$
30.00
Add to cart
Details
Lineamientos universales: Indíce de medicamentos para Latinoamérica
$
0.00
Add to cart
Details
Lithium-Induced Hyperparathyroidism: An Ill-defined Territory (OPEN ACCESS)
$
0.00
Add to cart
Details
Long Acting Injectables and their Correlation with Subjectivity in Schizophrenia Spectrum Disorder
$
30.00
Add to cart
Details
Long Acting Risperidone in an Adolescent – Mustafa Deniz Tutkunkardas
$
30.00
Add to cart
Details
Long-Acting Injectable Paliperidone Palmitate: A Review of Efficacy and Safety
$
30.00
Add to cart
Details
Long-Term Antidepressant Treatment
$
30.00
Add to cart
Details
Long-Term Outcomes of Post Dural Puncture Headache Treated With Epidural Blood Patch: A Pilot Study
$
30.00
Add to cart
Details
Long-Term Safety and Tolerability of Valbenazine (NBI-98854) in Subjects with Tardive Dyskinesia and a Diagnosis of Schizophrenia or Mood Disorder
$
0.00
Add to cart
Details
Long-Term Treatment Strategies in Affective Disorders
$
30.00
Add to cart
Details
Long-Term Treatment Strategies in Anxiety Disorders
$
30.00
Add to cart
Details
Lori Davis, MD: Clinical and Pharmacoeconomic Evaluation of Switch to Olanzapine in Veterans with Schizophrenia or Schizoaffective Disorder
$
30.00
Add to cart
Details
Low-Dose Risperidone for an Autistic Child with Comorbid ARFID and Misophonia
$
30.00
Add to cart
Details
Previous
1
…
21
22
23
…
44
Next
Page load link
Go to Top
